DexCom
DXCM
DXCM
730 hedge funds and large institutions have $33.9B invested in DexCom in 2020 Q4 according to their latest regulatory filings, with 118 funds opening new positions, 292 increasing their positions, 247 reducing their positions, and 106 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
10% less capital invested
Capital invested by funds: $37.8B → $33.9B (-$3.91B)
15% less call options, than puts
Call options by funds: $555M | Put options by funds: $654M
38% less funds holding in top 10
Funds holding in top 10: 13 → 8 (-5)
Holders
730
Holding in Top 10
8
Calls
$555M
Puts
$654M
Top Buyers
| 1 | +$645M | |
| 2 | +$438M | |
| 3 | +$206M | |
| 4 |
Capital International Investors
Los Angeles,
California
|
+$170M |
| 5 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$145M |
Top Sellers
| 1 | -$568M | |
| 2 | -$361M | |
| 3 | -$344M | |
| 4 |
GQG Partners
Ft. Lauderdale,
Florida
|
-$278M |
| 5 |
Goldman Sachs
New York
|
-$269M |